21231 ⎘
Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units Dendrimers; Multiple antigen peptides
PRE-FUSION-STABILIZED CMV GB PROTEIN NANOSTRUCTURES
#2OFF-THE-SHELF CANCER VACCINES
#3IMMUNIZATION STRATEGIES TO MORE NATURALLY GUIDE THE MATURATION OF ANTIBODIES AGAINST HUMAN IMMMUNODEFICIENCY VIRUS (HIV) IN HIV-INFECTED SUBJECTS
#4VIRUS POLYPEPTIDE-PROTEIN SUBUNIT COMBINATION VACCINE BASED ON DNA NANOTECHNOLOGY, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#5NOVEL METHODS TO ENHANCE GENE DELIVERY
#6ARTIFICIAL PROMISCUOUS T HELPER CELL EPITOPES THAT FACILITATE TARGETED ANTIBODY PRODUCTION WITH LIMITED T CELL INFLAMMATORY RESPONSE
#7NEOANTIGENS AND USES THEREOF
#8ASSEMBLED GLYCOPROTEINS
#9MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#10NANOSTRUCTURE-FORMING POLYPEPTIDES AND USES THEREOF
#11CONCATEMERIC PEPTIDE EPITOPE RNAS
#12COMPOSITIONS AND METHODS RELATED TO HIV-1 IMMUNOGENS
#13COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HIV INFECTION
#14RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
#15MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS
#16VACCINATION WITH MICA/B ALPHA 3 DOMAIN FOR THE TREATMENT OF CANCER
#17MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF
#18Anti-Abeta Therapeutic Vaccines
#19TRUNCATED INFLUENZA NEURAMINIDASE AND METHODS OF USING THE SAME
#20RECOMBINANT POLYPEPTIDES, CONJUGATES COMPRISING THE SAME, AND USES THEREOF
#21MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
#22NANOPARTICLES COMPRISING PEPTIDES INCLUDING AN N-TERMINAL LINKER
#23ORAL COMPOSITIONS AND USE OF SAME IN VACCINATION
#24IMMUNOGENIC COMPOSITIONS TARGETING RECURRENT CANCER MUTATIONS AND METHODS OF USE THEREOF
#25T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof
#26Unified platform for rapid production of nanovaccines with enhanced safety, efficacy and precision
#27Modified biotin-binding protein, fusion proteins thereof and applications
#28MODIFIED ENVELOPE PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS AND USE THEREOF
#29Nanoparticles comprising peptides including an n-terminal linker
#30MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof
#31Antigen presenting scaffolds for immune-cell manipulation
#32Sustained release cowpea mosaic virus or virus-like particle therapeutic constructs for the treatment of cancer
#33RATIONALLY ENGINEERED CARRIER PROTEINS FOR VACCINES
#34Recombinant proteins and their therapeutic uses
#35CONCATEMERIC PEPTIDE EPITOPE RNAS
#36PHAGOCYTISABLE PARTICLE FOR USE IN THE TREATMENT OR PROPHYLAXIS OF CANCER
#37HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion envelope conformations
#38CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF
#39CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF
#40HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
#41COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY
#42Multiple antigen presenting immunogenic composition, and methods and uses thereof
#43VACCINATION WITH MICA/B ALPHA 3 DOMAIN FOR THE TREATMENT OF CANCER
#44Sustained release cowpea mosaic virus or virus-like particle therapeutic constructs for the treatment of cancer
#45Neoantigens and uses thereof
#46OFF-THE-SHELF CANCER VACCINES
#47Combined prophylactic and therapeutic vaccines
#48Dendritic gold nanoparticles and methods of synthesis
#49Anti-abeta therapeutic vaccines
#50Modified biotin-binding protein, fusion proteins thereof and applications
#51Immunogenic RSV polypeptides
#52Methods and compositions employing immunogenic fusion proteins
#53Nucleic acids encoding HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion conformations
#54COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY
#55Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, bacillus anthracis and yersinia pestis
#56Compositions, methods and therapies for administering antigen peptide
#57Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
#58Antigen presenting scaffolds for immune-cell manipulation
#59Multi-epitope DNA vaccine for heartwater
#60Anti-abeta therapeutic vaccines
#61Method for preparing multimeric forms of the hepatitis c virus (HCV) envelope glycoprotein 2 (HCV E2)
#62HPV vaccines
#63Adjuvants
#64Multivalent glycoconjugate vaccines
#65Multivalent glycoconjugate vaccines
#66Method for Emulsifying a Triepitope Peptide with Montanide and Kits for Performing the Same
#67L2 peptide immunogenicity
#68Modified biotin-binding protein, fusion proteins thereof and applications
#69RESPIRATORY SYNCYTIAL VIRUS VACCINE
#70HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion conformations
#71Composition comprised of antigen linked to a TNF superfamily ligand
#72Concatemeric peptide epitope RNAs
#73Vectors for expression of prostate-associated antigens
#74Vaccination with MICA/B alpha 3 domain for the treatment of cancer
#75Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#76Microneedle compositions and methods of using same
#77Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, and
#78CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF
#79CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF
#80Recombinant proteins and their therapeutic uses
#81Compositions, methods and therapies for administering antigen peptide
#82Immunogenic RSV polypeptides
#83VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
#84Methods and compositions employing immunogenic fusion proteins
#85Virus Vectors Expressing Multiple Epitopes of Tumor Associated Antigens For Inducing Antitumor Immunity
#86Microneedle compositions and methods of using same
#87Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
#88Immunogenic Polypeptide Composed of HLA-B7 Restricted Tumor Antigen-Derived Optimized Cryptic Peptides, and Uses Thereof
#89Multivalent glycoconjugate vaccines
#90Mutant staphylococcal antigens
#91HUMAN CYTOMEGALOVIRUS VACCINE COMPOSITIONS AND METHOD OF PRODUCING THE SAME
#92Method of obtaining a polyepitopic protein and polyepitopic DNA vector
#93Composition comprising branched multipeptide vaccine and vaccine comprising the same
#94Soluble HIV-1 envelope glycoprotein trimers
#95Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof
#96METHOD FOR EMULSIFYING A TRIEPITOPE PEPTIDE WITH MONTANIDE AND KITS FOR PERFORMING THE SAME
#97Vault immunotherapy
#98Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof
#99Dock-and-Lock (DNL) Vaccines for Cancer Therapy
#100Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof
#101Respiratory syncytial virus vaccine
#102IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF
#103Anti-ganglioside compound for targeting cancer and generating antibodies
#104Soluble HIV-1 envelope glycoprotein trimers
#105Vectors for expression of prostate-associated antigens
#106RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
#107Methods and compositions related to immunogenic fibrils
#108Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
#109Protein matrix vaccines and related methods of making and administering such vaccines
#110Composition comprised of antigen linked to a TNF superfamily ligand
#111Modified biotin-binding protein, fusion proteins thereof and applications
#112Methods and compositions related to immunogenic fibrils
#113MAMMALIAN PROTEIN CO-RECOGNITION BY BROADLY NEUTRALIZING ANTIBODIES AS MODIFIED IMMUNOGENS FOR RE-ELICITATION
#114Immunogenic composition in emulsion form
#115Methods and compositions employing immunogenic fusion proteins
#116Peptide carrier fusion proteins as allergy vaccines
#117IMMUNOGENIC FRAGMENTS OF T-CELL RECEPTOR CONSTANT DOMAINS AND PEPTIDES DERIVED THEREFROM
#118Chimeric nucleic acid molecule with non-AUG translation initiation sequences
#119Anti-HER2 vaccine based upon AAV derived multimeric structures
#120Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine
#121Method for inducing an immune response and formulations thereof
#122Compositions, methods and therapies for administering antigen peptide
#123Multimeric multiepitope influenza vaccines
#124Recombinant proteins and their therapeutic uses
#125Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
#126Peptide carrier fusion proteins as allergy vaccines
#127Protein matrix vaccines and methods of making and administering such vaccines
#128Multiple antigen presenting immunogenic composition, and methods and uses thereof
#129Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use
#130Peptide analogues
#131RSV IMMUNOGENS, ANTIBODIES AND COMPOSITIONS THEREOF
#132Antigen peptide and use thereof
#133Methods and compositions related to immunogenic fibrils
#134Polyethylene glycol-based dendrons
#135IMMUNOGENIC STREPTOCOCCUS PNEUMONIAE PEPTIDES AND PEPTIDE-MULTIMERS
#136Vaccine compositions and methods of use thereof
#137INFLUENZA VIRUS COMPOSITIONS AND METHODS FOR UNIVERSAL VACCINES
#138CONJUGATES UTILIZING PLATFORM TECHNOLOGY FOR STIMULATING IMMUNE RESPONSE
#139INDUCTION OF MUCOSAL IMMUNE RESPONSES BY MUCOSAL DELIVERY PENTABODY COMPLEX (MDPC)
#140BSA-specific antibodies
#141Multimeric multiepitope influenza vaccines
#142Multi-component L2 vaccine for prevention of human papilloma virus infection
#143Anti-peptide antibodies that cross react with protective antigen of and uses thereof
#144Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine
#145MAGE-A3/HPV 16 PEPTIDE VACCINES FOR HEAD AND NECK CANCER
#146Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein
#147SUGAR IMMUNOGENS
#148IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR
#149Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use
#150Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes
#151PEPTIDE ANALOGUES
#152Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection
#153VACCINE
#154MAGE-A3/HPV 16 PEPTIDE VACCINES FOR HEAD AND NECK CANCER
#155HCV fusion polypeptides
#156Optimized multi-epitope constructs and uses thereof
#157Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA
#158DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES
#159Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
#160Nanoparticles comprising antigens and adjuvants, and immunogenic structures
#161Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom
#162Sugar immunogens
#163Protein matrix vaccines and methods of making and administering such vaccines
#164Multiple antigenic agents and methods for using the same
#165HPV 16 peptide vaccine for head and neck cancer
#166Vaccine for prevention and treatment of HIV-infection
#167MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE, VACCINE COMPRISING THE SAME AND USE THEREOF
#168Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
#169Immunogenic peptide carrier conjugates and methods of producing same
#170Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
#171PRAME peptide analogues
#172Melanoma antigen peptide analogues
#173PSMA peptide analogues
#174Optimized multi-epitope constructs and uses thereof
#175Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
#176Methods and compositions for treating and preventing inflammatory conditions
#177Multiepitope polypeptides for cancer immunotherapy
#178Hetero type pentamer recombinant vaccine
#179Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases
#180MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
#181Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use
#182Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides
#183Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
#184Composition and method for preventing or treating a virus infection
#185Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein
#186Methods and compositions comprising bacteriophage nanoparticles
#187aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
#188Norovirus monoclonal antibodies and peptides
#189Compositions of protein mimetics and methods of using same against HIV-1, SARS-coV and the like
#190Antigenic product displaying multiple copies of an epitope of a deposit-forming polypeptide involved in plaque-forming diseases and methods of using same
#191Glucan binding protein and glucosyltransferase immunogens
#192Glucosyltransferase immunogens
#193SARS-CoV-2 fusion protein vaccine/regimen